Furthermore, IGF-1 induces MUC1 expression, a glycoprotein engaged in multiple cancer-related pathways, via AKT signaling, promoting the translocation of β-catenin and EMT progression in MCF7 cells [124]. The gene discussed is IGF1; the disease is cancer.